Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disorders

Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disorders

US Patent 9364455 · Granted Jun 14, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Niclosamide formulations for treating disease2022
Methods and compositions for reducing side effects in chemotherapeutic treatment2022
Use of ivermectin and brimonidine in the treatment and/or prevention of moderate2022
Pharmaceutical composition comprising refined indigo naturalis extracts and the 2021
Niclosamide formulations for treating disease2021
Extract from Indigo Naturalis and a process for preparing the same2020
Antibacterial indigo naturalis or indigo-producing plant extract and use thereof2020
Pharmaceutical composition comprising refined Indigo naturalis extracts and the 2020
Extract from indigo naturalis and a process for preparing the same2019
Method of reducing hair loss associated with chemotherapy2019
Pharmaceutical composition comprising refined indigo naturalis extract and the u2019
Phenol derivatives and the pharmaceutical or cosmetic use thereof2019